drugset / Trial / NCT02459964

Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

NCT02459964

Phase 4 Completed 84 enrolled M.D. Anderson Cancer Center
RandomizedParallel-groupOpen-labelSupportive care

Summary

The goal of this clinical research study is to compare fentanyl nasal spray with a standard drug given by vein (hydromorphone hydrochloride) to help reduce pain related to cancer in patients coming to the emergency department.

Timeline

Start
2015-09-14
Primary completion
2020-06-21
Completion
2020-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 100 ug Intranasal
Comparator Hydromorphone Other / unclassified 1.5 mg Intravenous